We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.64B
AUM Growth
+$176M
Cap. Flow
+$130M
Cap. Flow %
7.88%
Top 10 Hldgs %
4.45%
Holding
2,011
New
451
Increased
540
Reduced
511
Closed
490

Top Buys

Rank Stock Value
1
BG icon
Bunge Global
BG
+$9.2M
2
YUMC icon
Yum China
YUMC
+$7.54M
3
GILD icon
Gilead Sciences
GILD
+$7.27M
4
PPL
PPL Corp
PPL
+$6.17M
5
BABA icon
Alibaba
BABA
+$5.79M

Top Sells

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$10.5M
2
NBIS
Nebius Group N.V.
NBIS
+$8.88M
3
TSLA icon
Tesla
TSLA
+$6.99M
4
BKNG icon
Booking.com
BKNG
+$6.63M
5
VEON icon
VEON
VEON
+$5.47M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.45%
2 Industrials 13.59%
3 Technology 12.59%
4 Healthcare 12.43%
5 Financials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCC icon
26
Warrior Met Coal
HCC
$4.26B
$4.39M 0.27%
+174,694
New +$4.38M
EXEL icon
27
Exelixis
EXEL
$14B
$4.37M 0.27%
143,594
+88,343
+160% +$2.35M
EXTR icon
28
Extreme Networks
EXTR
$3.92B
$4.34M 0.26%
346,617
+165,379
+91% +$2.04M
LAZ icon
29
Lazard
LAZ
$4.23B
$4.23M 0.26%
80,624
+14,605
+22% +$700K
NVR icon
30
NVR
NVR
$16.9B
$4.21M 0.26%
1,199
+819
+216% +$2.67M
BMY icon
31
Bristol-Myers Squibb
BMY
$128B
$4.2M 0.26%
68,580
+58,842
+604% +$3.68M
RHT
32
DELISTED
Red Hat Inc
RHT
$4.09M 0.25%
34,084
+25,005
+275% +$3.06M
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$122B
$3.94M 0.24%
26,307
+9,194
+54% +$1.36M
CCK icon
34
Crown Holdings
CCK
$12.9B
$3.93M 0.24%
69,788
+57,543
+470% +$3.4M
UPBD icon
35
Upbound Group
UPBD
$1.2B
$3.9M 0.24%
351,701
+18,798
+6% +$206K
AGN
36
DELISTED
Allergan plc
AGN
$3.87M 0.24%
23,627
+380
+2% +$68.2K
MU icon
37
Micron Technology
MU
$1.02T
$3.85M 0.23%
93,696
+16,299
+21% +$702K
DK icon
38
Delek US
DK
$3.95B
$3.85M 0.23%
110,219
+68,719
+166% +$2.03M
EBS icon
39
Emergent Biosolutions
EBS
$378M
$3.83M 0.23%
82,499
+68,699
+498% +$2.89M
GE icon
40
GE Aerospace
GE
$375B
$3.83M 0.23%
+45,744
New +$4.37M
GRA
41
DELISTED
W.R. Grace & Co.
GRA
$3.81M 0.23%
54,312
+31,857
+142% +$2.31M
HPQ icon
42
HP
HPQ
$24.3B
$3.8M 0.23%
180,668
+97,214
+116% +$2.07M
HK
43
DELISTED
Halcon Resources Corporation
HK
$3.77M 0.23%
498,281
+210,541
+73% +$1.44M
HRI icon
44
Herc Holdings
HRI
$5.34B
$3.76M 0.23%
60,105
-27,339
-31% -$1.51M
GKOS icon
45
Glaukos
GKOS
$8.92B
$3.7M 0.23%
144,168
+124,450
+631% +$3.7M
CELG
46
DELISTED
Celgene Corp
CELG
$3.63M 0.22%
34,830
+25,433
+271% +$2.87M
CAG icon
47
Conagra Brands
CAG
$7.29B
$3.63M 0.22%
96,416
+58,401
+154% +$2.07M
CSTM icon
48
Constellium
CSTM
$4.02B
$3.63M 0.22%
325,660
-61,148
-16% -$650K
CI icon
49
Cigna
CI
$77B
$3.62M 0.22%
17,802
+15,042
+545% +$2.99M
KLIC icon
50
Kulicke & Soffa
KLIC
$5.14B
$3.58M 0.22%
147,272
+69,512
+89% +$1.66M
1
2
3 4 5

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
TLFA
True Link Financial Advisors San Francisco, California $1.62B AUM 8.33% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

GSA Capital Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GSA Capital Partners held 2,011 positions worth $1.64B, up 12% from $1.47B the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

GSA Capital Partners deployed $130M of net new capital in Q4 2017, opening 451 new positions and adding to 540 existing holdings. Its largest new stake was PPL Corp: 171,648 shares worth $5.31M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Nebius Group N.V., an estimated $8.88M trimmed.

  • GSA Capital Partners's largest Q4 2017 buy was PPL Corp: 171,648 shares worth $5.31M.
  • GSA Capital Partners added most to Bunge Global in Q4 2017, an estimated $9.2M increase.
  • GSA Capital Partners's biggest Q4 2017 reduction was Nebius Group N.V., cutting an estimated $8.88M.
  • GSA Capital Partners fully exited Hilton Worldwide in Q4 2017, selling an estimated $10.5M.
  • GSA Capital Partners's ten largest holdings make up 4.5% of its $1.64B portfolio in Q4 2017.
  • GSA Capital Partners opened 451 new positions and closed 490 in Q4 2017.
  • GSA Capital Partners's portfolio value rose 12% quarter-over-quarter to $1.64B.

Based on GSA Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.